Delcath Systems, Inc. (DCTH) vs Phathom Pharmaceuticals, Inc. (PHAT)
A side-by-side comparison of Delcath Systems, Inc. and Phathom Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DCTH
Delcath Systems, Inc.
$15.51HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
PHAT
Phathom Pharmaceuticals, Inc.
$6.71HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — DCTH vs PHAT
growth of $100 · dividends reinvested · last 7yDCTH -71.7% (-16.5%/yr)PHAT -72.8% (-17.0%/yr)DCTH compounded faster over this window
DCTH PHAT
DCTH vs PHAT: by the numbers
- •PHAT is the larger company ($542M vs $535M market cap).
- •DCTH is profitable (0.56% net margin) while PHAT runs a net loss (-41.34%).
Metrics side by side
Valuation
| Metric | DCTH | PHAT |
|---|---|---|
| P/E ratio | 1193.07 | N/A |
| P/S ratio | 5.61 | 2.26 |
| P/B ratio | 4.42 | N/A |
| FCF yield | 3.27% | N/A |
Profitability
| Metric | DCTH | PHAT |
|---|---|---|
| Gross margin | 87.05% | 82.92% |
| Operating margin | -1.90% | -91.36% |
| Net margin | 0.56% | -41.34% |
| ROE | 0.44% | N/A |
| ROIC | -0.81% | -23.45% |
Growth (annualized)
| Metric | DCTH | PHAT |
|---|---|---|
| Revenue CAGR (5Y) | 118.96% | N/A |
| Total return CAGR (5Y) | 10.90% | -26.93% |
Frequently asked
- Is DCTH or PHAT more profitable?
- DCTH runs the higher net margin — DCTH at 0.56% versus PHAT at -41.34%.
- How have DCTH and PHAT total returns compared?
- Over the past 5 years, DCTH delivered 10.90% and PHAT delivered -26.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Delcath Systems P/E ratioDelcath Systems ROEPhathom Pharmaceuticals ROEDelcath Systems operating marginPhathom Pharmaceuticals operating marginDelcath Systems revenue growthPhathom Pharmaceuticals revenue growthDelcath Systems free cash flowPhathom Pharmaceuticals free cash flow
Delcath Systems & Phathom Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.